000			02364 a2200673 4500
005			20250517060901.0
264		0	_c20160928
008			201609s 0 0 eng d
022			_a1949-2553
024	7		_a10.18632/oncotarget.6167 _2doi
040			_aNLM _beng _cNLM
100	1		_aChang, Kun
245	0	0	_aCombination of circulating tumor cell enumeration and tumor marker detection in predicting prognosis and treatment effect in metastatic castration-resistant prostate cancer. _h[electronic resource]
260			_bOncotarget _cDec 2015
300			_a41825-36 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBiomarkers, Tumor _xblood
650	0	4	_aCell Count
650	0	4	_aCell Line, Tumor
650	0	4	_aDisease-Free Survival
650	0	4	_aDocetaxel
650	0	4	_aEpithelial-Mesenchymal Transition _xdrug effects
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHumans
650	0	4	_aKallikreins _xblood
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aNeoplasm Metastasis
650	0	4	_aNeoplastic Cells, Circulating _xdrug effects
650	0	4	_aNeoplastic Stem Cells _xchemistry
650	0	4	_aPredictive Value of Tests
650	0	4	_aPrednisone _xadministration & dosage
650	0	4	_aProportional Hazards Models
650	0	4	_aProspective Studies
650	0	4	_aProstate-Specific Antigen _xblood
650	0	4	_aProstatic Neoplasms, Castration-Resistant _xblood
650	0	4	_aReal-Time Polymerase Chain Reaction
650	0	4	_aReproducibility of Results
650	0	4	_aRisk Factors
650	0	4	_aSerum Albumin _xanalysis
650	0	4	_aSerum Albumin, Human
650	0	4	_aTaxoids _xadministration & dosage
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aKong, Yun-Yi
700	1		_aDai, Bo
700	1		_aYe, Ding-Wei
700	1		_aQu, Yuan-Yuan
700	1		_aWang, Yue
700	1		_aJia, Zhong-Wei
700	1		_aLi, Gao-Xiang
773	0		_tOncotarget _gvol. 6 _gno. 39 _gp. 41825-36
856	4	0	_uhttps://doi.org/10.18632/oncotarget.6167 _zAvailable from publisher's website
999			_c25383783 _d25383783